ÂÜÀòÂÒÂ×

Craig A. Tooman has served as President, CEO and Board Director at Aratana Therapeutics Inc. (NASDAQ: PETX) since January 2019, following his 6-year tenure as CFO. Craig has decades of executive level experience and a strong résumé of operational expertise, including in pet therapeutics and the broader pharmaceutical industry.

He played a vital role in successfully completing Aratana's initial public offering and has raised more than $5B in the course of his career. Craig has built strong business relationships and a successful track record in executive leadership roles for several pharmaceutical companies, including as CEO of Avanzar Medical, Inc. and CFO for Enzon Pharmaceuticals and Ikaria Inc. He’s also held key executive roles at ILEX Oncology, Inc. and Pharmacia Corporation. Craig earned an MBA in Finance from the University of Chicago and a BA in Economics from Kalamazoo College.